Skip to content
10-Q

Quarterly Report

BIOTECH ACQUISITION COMPANY

0001213900-22-027093

← back to feed
Filed
May 16, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$102.33K
Operating Cash Flow Q1 2022 · Mar 31, 2021 −$864.72K
Cash And Equivalents Q1 2022 · Mar 31, 2022 $104.06K
Cash And Equivalents Q1 2022 · Dec 31, 2021 $91.41K
Stockholders Equity Q1 2022 · Mar 31, 2022 −$22.47M
Stockholders Equity Q1 2022 · Dec 31, 2021 −$27.17M
Stockholders Equity restated Q1 2022 · Mar 31, 2021 −$17.74M
Stockholders Equity Q1 2022 · Dec 31, 2020 $20K
Current Liabilities Q1 2022 · Mar 31, 2022 $2.22M
Current Liabilities Q1 2022 · Dec 31, 2021 $313.81K
Total Liabilities Q1 2022 · Mar 31, 2022 $22.82M
Total Liabilities Q1 2022 · Dec 31, 2021 $27.47M
Current Assets Q1 2022 · Mar 31, 2022 $309.32K
Current Assets Q1 2022 · Dec 31, 2021 $299.46K
Total Assets Q1 2022 · Mar 31, 2022 $230.35M
Total Assets Q1 2022 · Dec 31, 2021 $230.32M
Net Income Q1 2022 · Mar 31, 2022 $4.68M
Net Income Q1 2022 · Mar 31, 2021 $2.55M
Operating Income Q1 2022 · Mar 31, 2022 −$1.9M
Operating Income Q1 2022 · Mar 31, 2021 −$147.07K